Government of Canada / Gouvernement du Canada
Symbol of the Government of Canada


Food and Drugs Act

Version of section 21.71 from 2020-05-23 to 2022-09-11:

Marginal note:Duty to publicize clinical trial information

 The holder of a therapeutic product authorization referred to in paragraph 30(1.2)(c) shall ensure that prescribed information concerning the clinical trial is made public within the prescribed time and in the prescribed manner.

  • 2014, c. 24, s. 3
  • 2019, c. 29, s. 168
Date modified: